MDAI
Spectral AI
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 2
consensus rating "Strong Buy"
EPS Below Expectations
Revenue Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About MDAI
Spectral Ai, Inc.
A Special Purpose Acquisition Company
Healthcare Technology
11/17/2020
04/06/2021
NASDAQ Stock Exchange
78
12-31
Common stock
2515 McKinney Avenue, Suite 1000, Dallas, Texas 75201
--
Spectral AI, Inc., was incorporated in Delaware on November 17, 2020. The company is an artificial intelligence company focused on predictive medical diagnosis. The company is putting a lot of effort into the development of DeepView System, an in-house developed AI-powered MSI device that has FDA BDD status since 2018. The company's DeepView System uses a proprietary AI algorithm to distinguish completely damaged, partially damaged and invisible healthy human tissue features, providing a "Day One" healing potential assessment in seconds. DeepView's output is specially designed to allow doctors to make more accurate, timely and informed decisions about the treatment of patients' wounds.
Company Financials
EPS
MDAI has released its 2024 Q4 earnings. EPS was reported at -0.41, versus the expected -0.14, missing expectations. The chart below visualizes how MDAI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MDAI has released its 2024 Q4 earnings report, with revenue of 7.60M, reflecting a YoY change of 43.82%, and net profit of -7.74M, showing a YoY change of -118.33%. The Sankey diagram below clearly presents MDAI’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
